Physiomics Share News (PYC)

Physiomics Optimistic On Virtual Tumour Platform Interest

UK MIDDAY BRIEFING: Oil Stocks Down As Oil Price Hits 4-Year Low

UK WINNERS & LOSERS: Imperial Tobacco Gains As Oil Stocks Slide

Physiomics Shares Jump On Disclosure Of Merck As Partner

UK MORNING BRIEFING: Legal & General, Imperial Tobacco Start Strongly

UK WINNERS & LOSERS: Banks Under Stress After EU Test Results

Physiomics Extends Collaboration With "Major" Pharmaceutical Company

Physiomics Launches Web-Based Cardiac Toxicity Prediction Service

Physiomics wins cancer therapy deal

Biology company Physiomics won a contract with an unidentified drug company on Thursday, boosting its shares by 18.75%. Under the deal, Physiomics will model immune therapy agents for cancer research by the end of the year on a fee-for-service basis. Physiomics' chief executive Mark Shadwick said:

Physiomics Wins Contract With Undisclosed Pharmaceutical Company

Physiomics Shares Surge On Diatech Pharmacogenetics Collaboration

LONDON (Alliance News) - Shares in Physiomics PLC surged Thursday, after it said it has signed a head of terms agreement for a new collaboration with Diatech Pharmacogenetics srl. The Oxford-based systems biology company said that, under the terms of the expected collaboration agreement, th

UK MIDDAY BRIEFING: Same Problems For M&S, WH Smith

LONDON (Alliance News) - Retailers Marks & Spencer and WH Smith Thursday reported better performances than of late, but still saw their shares decline as analysts worried that they still have a lot to do to fix their long-standing issues.

Marks

UK WINNERS & LOSERS: M&S, WH Smith Drop Sharply After Early Strength

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday. ------- FTSE 100 - WINNERS ------- Resolution, up 1%. The firm said its insurance and pensions provider Friends Life is scrapping active member

Physiomics To Show New Validation For Virtual Tumour Platform

LONDON (Alliance News) - Physiomics PLC said Thursday that it will be demonstrating a new validation of its Virtual Tumour Clinical Platform at a workshop in France, with a study that shows the platform can be used to make accurate predictions of clinical outcomes. The Virtual Tumour Clinic

Physiomics In Talks With Pharmaceutical Companies For VTC Platform

LONDON (Alliance News) - Physiomics PLC said Thursday that it is in discussions with pharmaceutical companies about starting the first project to use its Virtual Tumour Clinical platform to predict outcomes for a new pipeline drug. It will be presenting the first validation of its Virtual T